Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

Human Fetuin-A Rs4918 Polymorphism and its Association with Obesity in Healthy Persons and in Patients with Myocardial Infarction in Two Hungarian Cohorts.

Temesszentandrási G, Vörös K, Márkus B, Böröcz Z, Kaszás E, Prohászka Z, Falus A, Cseh K, Kalabay L.

Med Sci Monit. 2016 Aug 4;22:2742-50.

2.

Adipose Tissue Depots and Their Cross-Sectional Associations With Circulating Biomarkers of Metabolic Regulation.

Lee JJ, Britton KA, Pedley A, Massaro JM, Speliotes EK, Murabito JM, Hoffmann U, Ingram C, Keaney JF Jr, Vasan RS, Fox CS.

J Am Heart Assoc. 2016 May 4;5(5). pii: e002936. doi: 10.1161/JAHA.115.002936.

3.

Implication of hepatokines in metabolic disorders and cardiovascular diseases.

Jung TW, Yoo HJ, Choi KM.

BBA Clin. 2016 Mar 5;5:108-13. doi: 10.1016/j.bbacli.2016.03.002. Review.

4.

Fetuin-A, glycemic status, and risk of cardiovascular disease: The Multi-Ethnic Study of Atherosclerosis.

Aroner SA, St-Jules DE, Mukamal KJ, Katz R, Shlipak MG, Criqui MH, Kestenbaum B, Siscovick DS, de Boer IH, Jenny NS, Budoff MJ, Ix JH, Jensen MK.

Atherosclerosis. 2016 May;248:224-9. doi: 10.1016/j.atherosclerosis.2016.03.029.

PMID:
27038419
5.

Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the Spotlight.

Ballestri S, Nascimbeni F, Romagnoli D, Baldelli E, Targher G, Lonardo A.

Int J Mol Sci. 2016 Mar 9;17(3):355. doi: 10.3390/ijms17030355. Review.

6.

The Impact of Organokines on Insulin Resistance, Inflammation, and Atherosclerosis.

Choi KM.

Endocrinol Metab (Seoul). 2016 Mar;31(1):1-6. doi: 10.3803/EnM.2016.31.1.1. Review.

7.

Sitagliptin/Metformin Versus Insulin Glargine Combined With Metformin in Obese Subjects With Newly Diagnosed Type 2 Diabetes.

Ji M, Xia L, Cao J, Zou D.

Medicine (Baltimore). 2016 Mar;95(11):e2961. doi: 10.1097/MD.0000000000002961.

8.

Genome-wide Meta-analysis on the Sense of Smell Among US Older Adults.

Dong J, Yang J, Tranah G, Franceschini N, Parimi N, Alkorta-Aranburu G, Xu Z, Alonso A, Cummings SR, Fornage M, Huang X, Kritchevsky S, Liu Y, London S, Niu L, Wilson RS, De Jager PL, Yu L, Singleton AB, Harris T, Mosley TH Jr, Pinto JM, Bennett DA, Chen H.

Medicine (Baltimore). 2015 Nov;94(47):e1892. doi: 10.1097/MD.0000000000001892.

9.

Serum Fetuin-A Associated With Fatty Liver Index, Early Indicator of Nonalcoholic Fatty Liver Disease: A Strobe-Compliant Article.

Huang Y, Huang X, Ding L, Wang P, Peng K, Chen Y, Dai M, Zhang D, Xu M, Bi Y, Wang W.

Medicine (Baltimore). 2015 Sep;94(39):e1517. doi: 10.1097/MD.0000000000001517.

10.

Fetuin-A and risk of coronary heart disease: A Mendelian randomization analysis and a pooled analysis of AHSG genetic variants in 7 prospective studies.

Laugsand LE, Ix JH, Bartz TM, Djousse L, Kizer JR, Tracy RP, Dehghan A, Rexrode K, Lopez OL, Rimm EB, Siscovick DS, O'Donnell CJ, Newman A, Mukamal KJ, Jensen MK.

Atherosclerosis. 2015 Nov;243(1):44-52. doi: 10.1016/j.atherosclerosis.2015.08.031.

11.

Association of plasma Fetuin-A and clinical characteristics in patients with new-onset type 2 diabetes mellitus.

Yin L, Cai WJ, Zhu LY, Li J, Su XH, Wang XL, Chang XY, Sun K.

Int J Clin Exp Med. 2015 Jan 15;8(1):991-9.

12.

Hepatokines as a Link between Obesity and Cardiovascular Diseases.

Yoo HJ, Choi KM.

Diabetes Metab J. 2015 Feb;39(1):10-5. doi: 10.4093/dmj.2015.39.1.10. Review.

13.

Relationship between serum levels of fetuin-A with apo-A1, apo-B100, body composition and insulin resistance in patients with type 2 diabetes.

Shidfar F, Zarrati M, Khamseh ME, Haghighat N, Rostami A, Zolfaghari H.

Med J Islam Repub Iran. 2014 Sep 20;28:100.

14.
15.
16.

Plasma levels of fetuin-A and risk of coronary heart disease in US women: the Nurses' Health Study.

Sun Q, Jiménez MC, Townsend MK, Rimm EB, Manson JE, Albert CM, Rexrode KM.

J Am Heart Assoc. 2014 Jun 24;3(3):e000939. doi: 10.1161/JAHA.114.000939.

17.
18.

Circulating alanine transaminase (ALT) and γ-glutamyl transferase (GGT), but not fetuin-A, are associated with metabolic risk factors, at baseline and at two-year follow-up: the prospective Cyprus Metabolism Study.

Liu X, Hamnvik OP, Chamberland JP, Petrou M, Gong H, Christophi CA, Christiani DC, Kales SN, Mantzoros CS.

Metabolism. 2014 Jun;63(6):773-82. doi: 10.1016/j.metabol.2014.03.008.

19.

Cardiovascular disease in patients with non-alcoholic fatty liver disease.

Kantartzis K, Stefan N.

Ann Gastroenterol. 2012;25(3):276-277. No abstract available.

20.

Urinary kidney injury molecule 1 (KIM-1) and interleukin 18 (IL-18) as risk markers for heart failure in older adults: the Health, Aging, and Body Composition (Health ABC) Study.

Driver TH, Katz R, Ix JH, Magnani JW, Peralta CA, Parikh CR, Fried L, Newman AB, Kritchevsky SB, Sarnak MJ, Shlipak MG; Health ABC Study..

Am J Kidney Dis. 2014 Jul;64(1):49-56. doi: 10.1053/j.ajkd.2014.01.432.

Items per page

Supplemental Content

Support Center